Project Grant R01HL185682
Award Date 6/15/26
Completion Date 2/28/30
Dollars Obligated $802K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Providence, RI 02903, USA
Similar Awards
- Federal Grant Award Summary Duke University's Office of Research Administration received a $1,532,545 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective June 5, 2026, with completion targeted for February 29, 2028. The research project investigates the effects of income-based health insurance benefit designs on cardiovascular disease (CVD) outcomes and health disparities among working-age...
- Federal Grant Award Summary Rhode Island Hospital, a division of Lifespan Corporation, received a $391,392 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective September 8, 2025, with completion targeted for June 30, 2030. The award funds the development and evaluation of the Active, Nourished, and Empowered Teens (ANET) program, a modular nutrition and fitness intervention designed to address...
- Federal Project Grant Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded Brigham & Women's Hospital a $855,585 Project Grant (CFDA 93.837 – Cardiovascular Diseases Research) on August 20, 2025, to develop and test an antihypertensive self-titration intervention adapted for the U.S. primary care context. The project, scheduled for completion by July 31, 2028, addresses the critical public health challenge that nearly half of U.S. adults with hypertension lack adequate blood...
- Federal Grant Award Summary Temple University received a $237,750 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective August 1, 2025 through July 31, 2027. Under this R03 award, Principal Investigator Gabriella McLoughlin, PhD, MS, will conduct research investigating the impact of an equity-focused implementation strategy on participation and uptake of Universal School Meals (USM) among...
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded a Project Grant totaling $1,381,876 to the University of Alaska Fairbanks, with an award date of September 23, 2025 and ultimate completion date of July 31, 2027, under the Cardiovascular Diseases Research program (CFDA 93.837). The project, titled "Neqpiaput Iinruugut (Our Food is Medicine): Testing a Tribally-Driven Intervention to Prevent Heart Disease Among Alaska Native Communities," delivers...
- Federal Grant Award Summary Brigham & Women's Hospital Inc. received a $784,362 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective September 1, 2025, through May 31, 2030. The grant funds a research initiative titled "Beyond BMI: Role of Body Composition, Coronary Microvascular Dysfunction and HFPEF in Characterizing Cardiometabolic Disease Phenotypes." The research employs...
- Federal Grant Award Summary Brigham & Women's Hospital Inc. received a $201,426 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective September 1, 2025, through August 31, 2030. This training program in patient-oriented research in cardiovascular endocrinology provides comprehensive, curriculum-based training designed to address the documented decline in clinical investigators since 2000. The...
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded Tufts University School of Medicine a $1.12 million Project Grant (CFDA 93.837, Cardiovascular Diseases Research) on September 17, 2025, to conduct a multiethnic and multiomics analysis of longitudinal changes in DNA methylation (DNAM) and cardiovascular health. The four-year research initiative, concluding July 31, 2029, integrates longitudinal epigenome-wide DNAM data with behavioral, clinical, genetic,...
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded the University of Connecticut Health Center a $293,395 Project Grant (CFDA 93.837: Cardiovascular Diseases Research) effective August 15, 2025, with a completion date of July 31, 2028. This award supports the "Democratizing Access to Cleaner Residential Air" (DACRA) initiative, which investigates the efficacy and feasibility of low-cost Corsi-Rosenthal boxes as an intervention to reduce...
- Federal Project Grant Award Summary Rhode Island Hospital, a division of Lifespan Corporation, received a $1.3M Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) beginning August 1, 2025, with completion targeted for May 31, 2029. The grant funds research to elucidate molecular mechanisms by which coronary endothelial cells survive and proliferate under ischemic conditions (low oxygen and glucose) and to...